The Department of Defense (DOD) is inviting proposals for the Small Business Innovation Research (SBIR) program focused on the "Rapid Identification of Pathogens from Environmental Resources," specifically targeting military-relevant bacteria, viruses, and fungi. The objective is to develop and validate a material product capable of quickly identifying these pathogens from environmental sources, enhancing environmental surveillance as a tool for outbreak monitoring and public health efforts. This initiative is critical for military applications, including deployment site assessments and monitoring for infectious diseases, with the potential to significantly reduce costs and improve response times in pathogen detection. Proposals are due by April 23, 2025, and further details can be found at the provided source link: [SBIR Topic](https://www.sbir.gov/topics/11782).

OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Infectious Disease OBJECTIVE: This topic is intended for technology proven ready to move directly into Phase II and is accepting Direct to Phase II proposals only. Develop and validate a material product that can effectively and rapidly identify military relevant bacteria, viruses and/or fungi from environmental sources. DESCRIPTION: Environmental surveillance has become increasingly recognized as a potentially valuable tool for identifying and tracking pathogens. Environmental surveillance has proven useful for pathogens such as poliovirus and SARS-CoV-2 to monitor for outbreaks and vaccine response. The potential benefits of these surveillance efforts include being an early warning system, monitoring the effectiveness of an outbreak response, testing the effectiveness of hospital wastewater treatment systems, identifying environmental risk factors for disease transmission to be targeted by public health efforts and tracking emerging resistance to bacteria in a local community.1 Within the military, additional benefits include pre and during exercise monitoring, deployment site transmission risk assessments and source identification of outbreaks. The 2023 Department of Defense Biodefense Posture Review (BPR) identified the need to prioritize environmental bio surveillance in efforts to create an effective early warning system for force health protection. The BPR tasked the Department of Defense with accelerating its research and innovation in this area.2 A cost model analysis of wastewater surveillance compared to human swab surveillance for SARS-CoV-2 at US Air Force Bases calculated a $10-18.5 million decrease in costs for wastewater surveillance.3 Identifying a faster detection method will not only further reduce costs but provide faster results. While most of the recent impetus on environmental surveillance has been focused on SARS-CoV-2, additional pathogens are also now targeted for monitoring. The CDC National Wastewater Surveillance System monitors for influenza, RSV, Mpox and SARS-CoV-2. The National Academies of Sciences, Engineering, and Medicine identified antimicrobial resistant bacteria as ideal targets for wastewater surveillance based on the public health need, feasibility, and usefulness of community wide data.4 One of the major limitations to environmental surveillance are the laboratory supplies and equipment, analysis time and training required. As a result, routine surveillance in the most likely environments for outbreaks or deployed settings is often unattainable. US Army Public Health Command have developed a deployment risk assessment guide for gastrointestinal illness from reused wastewater based on E.coli found in the water. Without the capability to measure E. coli in the field, this tool will go underutilized. A product that could be adapted to measure other pathogens would allow for the creation and application of similar tools that assess risk for skin and upper respiratory infections due to water or other environmental exposures. Current Periodic Occupational and Environmental Monitoring Summaries (POEMS) of deployment sites do not directly assess for microbiological risks but focus on particulate matter size and metals in the air, organic compounds, metals, pesticides in the soil and chemicals in the water. This topic area aims to support the development of a fast, easy to use, adaptable and durable product for the detection of military relevant viruses, bacteria and/or fungi from environmental samples. PHASE I: This topic is intended for technology proven ready to move directly into Phase II. Therefore, the offeror must be able to demonstrate and provide documentation to substantiate that the scientific and technical merit and feasibility described in Phase I has been met and describes the potential commercial applications. Documentation should include all relevant information including, but not limited to technical reports, test data, prototype designs/models, and performance goals/results. A completed Phase I will have demonstrated successful feasibility testing of a product that can identify at least one military relevant virus, bacteria of fungi from at least one environmental source. The feasibility testing could have been on actual environmental samples or spiked samples with a traditional laboratory comparator. The identification technology should have the potential to be expanded to other pathogens. Ideally, the product should be able to identify the target pathogen at the species level. Data on time to detection, repeatability, reproducibility and limits of detection on environmental samples should be provided. The pathogen identified should not be a potential biowarfare/incident agent but biological threats that could impact the military from the environment whether that is from wound infection risk, highly transmissible pathogens or potential pandemic threats. The environmental source could be air, water or soil. In addition, specifications of the planned prototype should be provided. PHASE II: This phase will focus on the development and testing of a prototype. The objectives for Phase II include the construction of a prototype that addresses the REASSURED WHO guidelines for point of care testing. Priorities for product design and technology should be in time to identification with a goal of less than 4 hours, minimal to no pre-processing of the source sample, ease of use, minimal energy requirements and capacity for adapting the detection technology to other pathogens/sample sources. The size of the prototype should be amenable to easy transportation and implementation by 1-2 people. Weight should be limited to approximately 30-45 pounds. Ideally, the prototype will be comprised of one unit that collects, processes and analyzes the environmental material. Include details on further development plans for a product that is durable and can be used in austere conditions. The performance of further feasibility testing during this Phase will be conducted. By the end of Phase II, a prototype that demonstrates the reliable identification of at least one virus, bacteria, or fungi from at least one environmental source. Enough prototypes should be constructed to meet Phase II testing goals. PHASE III DUAL USE APPLICATIONS: In addition during this phase expansion to other pathogens and environmental sources should occur. This product could be used by civilian and military hospitals to assess their wastewater treatment systems, implemented into environmental monitoring programs such as those in food factories, used by public health organizations as an early warning system for potential outbreaks or identify public health risk contributors (eg. antibiotic resistant bacteria found in run-off from farms treating animals with antibiotics). The product could be utilized for wide scale surveillance programs such as those funded by the DoD’s Global Emerging Infections Surveillance program. Potential military benefits could include incorporating biological threat testing into their environmental risk assessments of deployment and field exercise sites worldwide. Funding for further development efforts could be sought from such programs as the Joint Warfighter Medical Research Program, Biomedical Advanced Research and Development Authority or Medical Technology Enterprise Consortium. REFERENCES: 1. Grassly NC, Shaw AG, Owusu M. Global wastewater surveillance for pathogens with pandemic potential: opportunities and challenges. Lancet Microbe. 2024 Aug 30:100939. doi: 10.1016/j.lanmic.2024.07.002. Epub ahead of print. PMID: 39222653. 2. Department of Defense. Biodefense Posture Review. 2023. https://media.defense.gov/2023/Aug/17/2003282337/-1/-1/1/2023_biodefense_posture_review.pdf 3. Sanjak JS, McAuley EM, Raybern J, Pinkham R, Tarnowski J, Miko N, Rasmussen B, Manalo CJ, Goodson M, Stamps B, Necciai B, Sozhamannan S, Maier EJ. Wastewater Surveillance Pilot at US Military Installations: Cost Model Analysis. JMIR Public Health Surveill. 2024 Sep 6;10:e54750. doi: 10.2196/54750. PMID: 39240545; PMCID: PMC11396592. 4. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division on Earth and Life Studies; Board on Population Health and Public Health Practice; Water Science and Technology Board; Committee on Community Wastewater-based Infectious Disease Surveillance. Wastewater-based Disease Surveillance for Public Health Action. Washington (DC): National Academies Press (US); 2023 Jan 19. PMID: 37184191. KEYWORDS: Environmental surveillance, environmental bioburden, early warning system, outbreak detection, pandemic preparedness

Topic

Agency

Program

Topic Link

Additional Information